ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.20
      0.09%
      US Tech 100
      19,850.80
      0.02%
      Dow Jones
      39,447.92
      0.18%
      Brent Oil
      86.015
      -0.57%
      Bitcoin
      56,397.60
      0.99%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Antares Pharma Inc (ATRS)

      7. Antares Pharma Inc (ATRS) News

      ATRS

      Antares Pharma (ATRS)

      Antares Pharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRS
      DateTimeSourceHeadlineSymbolCompany
      12/16/20214:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      12/15/20215:58PMGlobeNewswire Inc.Antares Pharma Announces Divestiture of Otrexup®NASDAQ:ATRSAntares Pharma Inc
      11/22/20218:00AMGlobeNewswire Inc.Antares Pharma to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      11/10/20218:30AMGlobeNewswire Inc.Antares Pharma to Present at the Jefferies London Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      11/04/20214:42PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
      11/04/20217:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      11/04/20217:00AMGlobeNewswire Inc.Antares Pharma Reports Third Quarter 2021 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      11/02/20214:54PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      10/29/20216:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      10/28/20218:14AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      10/28/20218:00AMGlobeNewswire Inc.Antares Pharma Announces Appointment of Carmen Volkart to its Board of DirectorsNASDAQ:ATRSAntares Pharma Inc
      10/25/20218:30AMGlobeNewswire Inc.Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNANASDAQ:ATRSAntares Pharma Inc
      10/21/20218:30AMGlobeNewswire Inc.Antares Pharma to Report Third Quarter 2021 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      10/18/20217:56AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      10/18/20217:00AMGlobeNewswire Inc.Antares Pharma Enters into Exclusive License Agreement With Lipocine for TLANDO® in U.S.NASDAQ:ATRSAntares Pharma Inc
      09/30/20219:00AMGlobeNewswire Inc.Antares Pharma Initiates Phase I Study For ATRS-1902 For Adrenal Crisis RescueNASDAQ:ATRSAntares Pharma Inc
      09/08/20218:30AMGlobeNewswire Inc.Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceNASDAQ:ATRSAntares Pharma Inc
      08/31/20216:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      08/18/202110:43AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      08/05/20215:20PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
      08/05/20218:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      08/05/20217:00AMGlobeNewswire Inc.Antares Pharma Reports Second Quarter 2021 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      07/28/20218:30AMGlobeNewswire Inc.Antares Pharma to Report Second Quarter 2021 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      07/22/20218:30AMGlobeNewswire Inc.Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis RescueNASDAQ:ATRSAntares Pharma Inc
      07/07/20218:30AMGlobeNewswire Inc.Antares Pharma to Present at the Ladenburg Thalmann Annual Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      06/28/20218:30AMGlobeNewswire Inc.Antares Pharma Announces Partner Idorsia Initiates the Phase 3 Study With Selatogrel for Acute Myocardial InfarctionNASDAQ:ATRSAntares Pharma Inc
      06/24/20214:02PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ATRSAntares Pharma Inc
      06/22/20219:00AMGlobeNewswire Inc.Antares Pharma Announces Submission of IND Application for ATRS-1902 for Adrenal Crisis RescueNASDAQ:ATRSAntares Pharma Inc
      06/15/20214:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      06/15/20218:30AMGlobeNewswire Inc.Antares Pharma to Present at the Raymond James Human Health Innovations ConferenceNASDAQ:ATRSAntares Pharma Inc
       Showing the most relevant articles for your search:NASDAQ:ATRS